RE: Covid-related stocks27 Feb 2021 16:32
After a mixed bag for the Synairgen (SNG) share price over the months since i last posted, it's worth doing some research into at the mo imho, unless you're already invested. With ongoing trials into its therapuetic drug SNG001 likely to be yielding results in the near future, things could start to warm up in anticipation of the results being good and Emergency Use Authorisation being given to this drug in treating Covid 19 patients around the World. The USA may be the first to do so ? I am a lay person in therapuetics and this is just mho, so please as always, do your own research. atb